See a complete PubMed list of publications by Lali Medina-Kauwe, PhD.

Selected Key Publications

Sims JD, Taguiam JM, Alonso-Valenteen F, Markman J, Agadjanian H, Chu D, Lubow J, Abrol R, Srinivas D, Jain A, Han B, Qu Y, Mirzadehgan P, Hwang JY, Rentsendorj A, Chung A, Lester J, Karlan BY, Gray HB, Gross Z, Giuliano A, Cui X, Medina-Kauwe LK. Resistance to receptor-blocking therapies primes tumors as targets for HER3-homing nanobiologics. J Control Release. 2018 Feb 10;271:127-138.

Sims JD, Hwang JY, Wagner S, Alonso-Valenteen F, Hanson C, Taguiam JM, Polo R, Harutyunyan I, Karapetyan G, Sorasaenee K, Ibrahim A, Marban E, Moats R, Gray HB, Gross Z, Medina-Kauwe LK. A corrole nanobiologic elicits tissue-activated MRI contrast enhancement and tumor-targeted toxicity. J Control Release. 2015 Aug 31;217:92-101.

Hwang JY, Farkas DL, Medina-Kauwe LK. Analysis of targeted viral protein nanoparticles delivered to HER2+ tumors. J Vis Exp. 2013 Jun 18;(76).

Medina-Kauwe LK. Development of adenovirus capsid proteins for targeted therapeutic delivery. Ther Deliv. 2013;4(2):267-277.

Hwang JY, Lubow DJ, Chu D, Sims J, Alonso-Valenteen F, Gray HB, Gross Z, Farkas DL, Medina-Kauwe LK. Photoexcitation of tumor-targeted corroles induces singlet oxygen-mediated augmentation of cytotoxicity. J Control Release. 2012;163(3):368-373.

Hwang JY, Park J, Kang BJ, Lubow DJ, Chu D, Farkas DL, Shung KK, Medina-Kauwe LK. Multimodality imaging in vivo for preclinical assessment of tumor-targeted doxorubicin nanoparticles. PLOS One. 2012;7(4):e34463.

Agadjanian H, Chu D, Hwang JY, Wachsmann-Hogiu S, Rentsendorj A, Song L, Valluripalli V, Lubow J, Ma J, Sharifi B, Farkas DL, Medina-Kauwe LK. Chemotherapy targeting by DNA capture in viral protein particles. Nanomedicine. 2012;7(3):335-352.

Hwang JY, Lubow J, Chu D, Ma J, Agadjanian H, Gray HB, Gross Z, Farkas DL, Medina-Kauwe LK. A mechanistic study of tumor-targeted corrole cytotoxicity. Mol Pharm. 2011;8(6):2233-2243.

Agadjanian H, Ma J, Rentsendorj A, Valluripalli V, Hwang JY, Mahammed A, Farkas DL, Gray HB, Gross Z, Medina-Kauwe LK. Tumor detection and elimination by a targeted gallium corrole. Proc Natl Acad Sci USA. 2009;106(15):6105-6110.

Medina-Kauwe LK. "Alternative" endocytic mechanisms exploited by pathogens: new avenues for therapeutic delivery? Adv Drug Deliv Rev. 2007;59(8):798-809.

Xie J, Chiang L, Contreras J, Wu K, Garner JA, Medina-Kauwe L, Hamm-Alvarez SF. Novel fiber-dependent entry mechanism for adenovirus serotype 5 in lacrimal acini. J Virol. 2006;80(23):11833-11851.

Rentsendorj A, Xie J, MacVeigh M, Agadjanian H, Bass S, Hamm-Alvarez S, Medina-Kauwe LK. Typical and atypical trafficking pathways of Ad5 penton base recombinant protein: implications for gene transfer. Gene Ther. 2006;13(10):821-836.

Agadjanian H, Weaver JJ, Mahammed A, Rentsendorj A, Bass S, Kim J, Dmochowski IJ, Margalit R, Gray HB, Gross Z, Medina-Kauwe LK. Specific delivery of corroles to cells via noncovalent conjugates with viral proteins. Pharm Res. 2006;23(2):367-377.

Candolfi M, Curtin JF, Xiong W, Kroeger KM, Liu C, Rentsendorj A, Agadjanian H, Medina-Kauwe L, Palmer D, Ng P, et al. Effective High Capacity Gutless Adenoviral Vectors Mediated Transgene Expression in Human Glioma Cells, Molecular Therapy. 2006;14(3):371-81.

Medina-Kauwe LK. Endocytosis of adenovirus and adenovirus capsid proteins. Adv Drug Del Rev. 2003;55(11):1485-1496.